{"id":{"repo_id":"dundee","oai_identifier":"oai:discovery.dundee.ac.uk:studenttheses/39cd7ecc-d09b-4295-933e-725538437046"},"canonical_url":"https://search.dev.ndltd.org/etd/dundee/oai:discovery.dundee.ac.uk:studenttheses/39cd7ecc-d09b-4295-933e-725538437046","repository":{"repo_id":"dundee","name":"University of Dundee","base_url":"https://discovery.dundee.ac.uk/ws/oai"},"display":{"title":"The Development of Photo-crosslinkable Trapping Mutants as Tools to Investigate the Interactions of Protein Tyrosine Phosphatases","abstract":"Abnormalities in the coordinated activities of protein phosphatases (PPs) and<br/>protein kinases (PKs) contribute to the development of many diseases.<br/>Phosphatase of regenerating liver (PRL)-3 and Vaccinia H1-Related (VHR) are<br/>two members of the protein tyrosine phosphatase (PTP) family shown to be<br/>involved in cancer. PRL-3 is a member of the PRL phosphatases containing a<br/>unique post-translationally modifiable prenylation CAAX motif at the carboxy<br/>(C)- terminal end. There is an immense body of evidence to support a role for<br/>PRL-3 in the development of various types of cancer and in progression to<br/>metastasic disease. However, many questions are still pending, especially with<br/>respect to the identity of physiological substrates, and interacting partners in<br/>general, of PRL-3. VHR is a model for a group of atypical dual specificity<br/>protein phosphatases (DUSPs) with a role in cell cycle progression. Only a few<br/>of VHR’s physiological substrates have been reported to date and there are<br/>very few studies addressing its regulation and physiological role(s).<br/>Generally, in order to isolate and identify transient phosphatase-substrate<br/>interactions, substrate-trapping mutants of PTPs are employed. Mutants which<br/>can function as substrate traps have the ability to recognise and bind<br/>substrates, yet they lack functionality of the key catalytic residues and cannot<br/>efficiently process the hydrolysis of the substrate. However, it is acknowledged<br/>that the efficiency of such standard substrate-trapping mutants of PTPs is low.<br/>In this work, the expanded genetic code approach was applied to develop more<br/>efficient substrate trapping variants of the PTPs by incorporating the photocross-linkable amino acid para-benzoylphenylalanine (pBPA). The concept was optimised for PRL-3 and VHR, and for both proteins, pBPA-containing variantswere expressed at excellent yields and were highly purified.<br/>By utilizing the photo-cross-linkable F68pBPA variant of VHR, dimerisation of<br/>VHR was detected in an in vitro ultraviolet (UV) exposure-mediated crosslinking<br/>assay. VHR dimerisation was further demonstrated to be a potential<br/>novel regulatory mechanism for VHR, having a negative effect on the catalytic<br/>activity of the protein. A specific region in VHR known as the variable insert<br/>segment was pinpointed as a region in the protein, which is either at the dimer<br/>interface or heavily contributing to dimeric association. Furthermore, the<br/>intrinsic ability of VHR to self-associate was also demonstrated by<br/>complementary methods.<br/>For PRL-3 it was demonstrated that its D72pBPA variant could recognise and<br/>bind to lipids, with a stronger signal detected in the UV-exposed sample, and<br/>without altering the lipid binding profile with respect to the native protein. Lastly, the potential of exploiting photo-cross-linkable variants of the PTPs was also demonstrated by incubating PRL-3 variants, with or without selectively<br/>introduced pBPA, with mammalian cell lysates, followed by UV exposure.<br/>Western blot analysis detected new bands corresponding to covalently crosslinked PRL-3-protein complexes. Future work in our laboratory will follow up on these newly identified interactions.","abstract_html":"Abnormalities in the coordinated activities of protein phosphatases (PPs) and&lt;br/&gt;protein kinases (PKs) contribute to the development of many diseases.&lt;br/&gt;Phosphatase of regenerating liver (PRL)-3 and Vaccinia H1-Related (VHR) are&lt;br/&gt;two members of the protein tyrosine phosphatase (PTP) family shown to be&lt;br/&gt;involved in cancer. PRL-3 is a member of the PRL phosphatases containing a&lt;br/&gt;unique post-translationally modifiable prenylation CAAX motif at the carboxy&lt;br/&gt;(C)- terminal end. There is an immense body of evidence to support a role for&lt;br/&gt;PRL-3 in the development of various types of cancer and in progression to&lt;br/&gt;metastasic disease. However, many questions are still pending, especially with&lt;br/&gt;respect to the identity of physiological substrates, and interacting partners in&lt;br/&gt;general, of PRL-3. VHR is a model for a group of atypical dual specificity&lt;br/&gt;protein phosphatases (DUSPs) with a role in cell cycle progression. Only a few&lt;br/&gt;of VHR’s physiological substrates have been reported to date and there are&lt;br/&gt;very few studies addressing its regulation and physiological role(s).&lt;br/&gt;Generally, in order to isolate and identify transient phosphatase-substrate&lt;br/&gt;interactions, substrate-trapping mutants of PTPs are employed. Mutants which&lt;br/&gt;can function as substrate traps have the ability to recognise and bind&lt;br/&gt;substrates, yet they lack functionality of the key catalytic residues and cannot&lt;br/&gt;efficiently process the hydrolysis of the substrate. However, it is acknowledged&lt;br/&gt;that the efficiency of such standard substrate-trapping mutants of PTPs is low.&lt;br/&gt;In this work, the expanded genetic code approach was applied to develop more&lt;br/&gt;efficient substrate trapping variants of the PTPs by incorporating the photocross-linkable amino acid para-benzoylphenylalanine (pBPA). The concept was optimised for PRL-3 and VHR, and for both proteins, pBPA-containing variantswere expressed at excellent yields and were highly purified.&lt;br/&gt;By utilizing the photo-cross-linkable F68pBPA variant of VHR, dimerisation of&lt;br/&gt;VHR was detected in an in vitro ultraviolet (UV) exposure-mediated crosslinking&lt;br/&gt;assay. VHR dimerisation was further demonstrated to be a potential&lt;br/&gt;novel regulatory mechanism for VHR, having a negative effect on the catalytic&lt;br/&gt;activity of the protein. A specific region in VHR known as the variable insert&lt;br/&gt;segment was pinpointed as a region in the protein, which is either at the dimer&lt;br/&gt;interface or heavily contributing to dimeric association. Furthermore, the&lt;br/&gt;intrinsic ability of VHR to self-associate was also demonstrated by&lt;br/&gt;complementary methods.&lt;br/&gt;For PRL-3 it was demonstrated that its D72pBPA variant could recognise and&lt;br/&gt;bind to lipids, with a stronger signal detected in the UV-exposed sample, and&lt;br/&gt;without altering the lipid binding profile with respect to the native protein. Lastly, the potential of exploiting photo-cross-linkable variants of the PTPs was also demonstrated by incubating PRL-3 variants, with or without selectively&lt;br/&gt;introduced pBPA, with mammalian cell lysates, followed by UV exposure.&lt;br/&gt;Western blot analysis detected new bands corresponding to covalently crosslinked PRL-3-protein complexes. Future work in our laboratory will follow up on these newly identified interactions.","abstract_has_math":false,"creators":["Pavic, Karolina"],"institution":"University of Dundee","degree_name":"Doctor of Philosophy","degree_level":"Doctoral Thesis","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["Keyse, Stephen","Kohn, Maja","Krijgsveld , Jeroen","Lemke, Edward"],"committee_chairs":[],"committee_members":[],"year":2013,"date_issued":"2013","date_published":"2013","updated_at":"2026-07-24T02:07:52Z","subjects":[],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["oai:discovery.dundee.ac.uk:studenttheses/39cd7ecc-d09b-4295-933e-725538437046"],"render_values":[{"text":"oai:discovery.dundee.ac.uk:studenttheses/39cd7ecc-d09b-4295-933e-725538437046","href":null,"code":true}]}]},"links":{"outbound_url":"https://discovery.dundee.ac.uk/en/studentTheses/39cd7ecc-d09b-4295-933e-725538437046","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Keyse, Stephen","Kohn, Maja","Krijgsveld , Jeroen","Lemke, Edward"]},{"key":"dc:creator","label":"Author","values":["Pavic, Karolina"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2013"]},{"key":"dc:date.issued","label":"Date","values":["2013"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Dundee","European Molecular Biology Laboratory"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://discovery.dundee.ac.uk/en/studentTheses/39cd7ecc-d09b-4295-933e-725538437046"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["Doctoral Thesis"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["Doctor of Philosophy"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["oai:discovery.dundee.ac.uk:studenttheses/39cd7ecc-d09b-4295-933e-725538437046","https://discovery.dundee.ac.uk/en/studentTheses/39cd7ecc-d09b-4295-933e-725538437046"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://discovery.dundee.ac.uk/files/4439298/Pavic_phd_2013.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Abnormalities in the coordinated activities of protein phosphatases (PPs) and<br/>protein kinases (PKs) contribute to the development of many diseases.<br/>Phosphatase of regenerating liver (PRL)-3 and Vaccinia H1-Related (VHR) are<br/>two members of the protein tyrosine phosphatase (PTP) family shown to be<br/>involved in cancer. PRL-3 is a member of the PRL phosphatases containing a<br/>unique post-translationally modifiable prenylation CAAX motif at the carboxy<br/>(C)- terminal end. There is an immense body of evidence to support a role for<br/>PRL-3 in the development of various types of cancer and in progression to<br/>metastasic disease. However, many questions are still pending, especially with<br/>respect to the identity of physiological substrates, and interacting partners in<br/>general, of PRL-3. VHR is a model for a group of atypical dual specificity<br/>protein phosphatases (DUSPs) with a role in cell cycle progression. Only a few<br/>of VHR’s physiological substrates have been reported to date and there are<br/>very few studies addressing its regulation and physiological role(s).<br/>Generally, in order to isolate and identify transient phosphatase-substrate<br/>interactions, substrate-trapping mutants of PTPs are employed. Mutants which<br/>can function as substrate traps have the ability to recognise and bind<br/>substrates, yet they lack functionality of the key catalytic residues and cannot<br/>efficiently process the hydrolysis of the substrate. However, it is acknowledged<br/>that the efficiency of such standard substrate-trapping mutants of PTPs is low.<br/>In this work, the expanded genetic code approach was applied to develop more<br/>efficient substrate trapping variants of the PTPs by incorporating the photocross-linkable amino acid para-benzoylphenylalanine (pBPA). The concept was optimised for PRL-3 and VHR, and for both proteins, pBPA-containing variantswere expressed at excellent yields and were highly purified.<br/>By utilizing the photo-cross-linkable F68pBPA variant of VHR, dimerisation of<br/>VHR was detected in an in vitro ultraviolet (UV) exposure-mediated crosslinking<br/>assay. VHR dimerisation was further demonstrated to be a potential<br/>novel regulatory mechanism for VHR, having a negative effect on the catalytic<br/>activity of the protein. A specific region in VHR known as the variable insert<br/>segment was pinpointed as a region in the protein, which is either at the dimer<br/>interface or heavily contributing to dimeric association. Furthermore, the<br/>intrinsic ability of VHR to self-associate was also demonstrated by<br/>complementary methods.<br/>For PRL-3 it was demonstrated that its D72pBPA variant could recognise and<br/>bind to lipids, with a stronger signal detected in the UV-exposed sample, and<br/>without altering the lipid binding profile with respect to the native protein. Lastly, the potential of exploiting photo-cross-linkable variants of the PTPs was also demonstrated by incubating PRL-3 variants, with or without selectively<br/>introduced pBPA, with mammalian cell lysates, followed by UV exposure.<br/>Western blot analysis detected new bands corresponding to covalently crosslinked PRL-3-protein complexes. Future work in our laboratory will follow up on these newly identified interactions."]},{"key":"dc:title","label":"Title","values":["The Development of Photo-crosslinkable Trapping Mutants as Tools to Investigate the Interactions of Protein Tyrosine Phosphatases"]}]}],"canonical_facts":{"dc:contributor.advisor":["Keyse, Stephen","Kohn, Maja","Krijgsveld , Jeroen","Lemke, Edward"],"dc:creator":["Pavic, Karolina"],"dc:date":["2013"],"dc:date.issued":["2013"],"dc:description.abstract":["Abnormalities in the coordinated activities of protein phosphatases (PPs) and<br/>protein kinases (PKs) contribute to the development of many diseases.<br/>Phosphatase of regenerating liver (PRL)-3 and Vaccinia H1-Related (VHR) are<br/>two members of the protein tyrosine phosphatase (PTP) family shown to be<br/>involved in cancer. PRL-3 is a member of the PRL phosphatases containing a<br/>unique post-translationally modifiable prenylation CAAX motif at the carboxy<br/>(C)- terminal end. There is an immense body of evidence to support a role for<br/>PRL-3 in the development of various types of cancer and in progression to<br/>metastasic disease. However, many questions are still pending, especially with<br/>respect to the identity of physiological substrates, and interacting partners in<br/>general, of PRL-3. VHR is a model for a group of atypical dual specificity<br/>protein phosphatases (DUSPs) with a role in cell cycle progression. Only a few<br/>of VHR’s physiological substrates have been reported to date and there are<br/>very few studies addressing its regulation and physiological role(s).<br/>Generally, in order to isolate and identify transient phosphatase-substrate<br/>interactions, substrate-trapping mutants of PTPs are employed. Mutants which<br/>can function as substrate traps have the ability to recognise and bind<br/>substrates, yet they lack functionality of the key catalytic residues and cannot<br/>efficiently process the hydrolysis of the substrate. However, it is acknowledged<br/>that the efficiency of such standard substrate-trapping mutants of PTPs is low.<br/>In this work, the expanded genetic code approach was applied to develop more<br/>efficient substrate trapping variants of the PTPs by incorporating the photocross-linkable amino acid para-benzoylphenylalanine (pBPA). The concept was optimised for PRL-3 and VHR, and for both proteins, pBPA-containing variantswere expressed at excellent yields and were highly purified.<br/>By utilizing the photo-cross-linkable F68pBPA variant of VHR, dimerisation of<br/>VHR was detected in an in vitro ultraviolet (UV) exposure-mediated crosslinking<br/>assay. VHR dimerisation was further demonstrated to be a potential<br/>novel regulatory mechanism for VHR, having a negative effect on the catalytic<br/>activity of the protein. A specific region in VHR known as the variable insert<br/>segment was pinpointed as a region in the protein, which is either at the dimer<br/>interface or heavily contributing to dimeric association. Furthermore, the<br/>intrinsic ability of VHR to self-associate was also demonstrated by<br/>complementary methods.<br/>For PRL-3 it was demonstrated that its D72pBPA variant could recognise and<br/>bind to lipids, with a stronger signal detected in the UV-exposed sample, and<br/>without altering the lipid binding profile with respect to the native protein. Lastly, the potential of exploiting photo-cross-linkable variants of the PTPs was also demonstrated by incubating PRL-3 variants, with or without selectively<br/>introduced pBPA, with mammalian cell lysates, followed by UV exposure.<br/>Western blot analysis detected new bands corresponding to covalently crosslinked PRL-3-protein complexes. Future work in our laboratory will follow up on these newly identified interactions."],"dc:identifier":["oai:discovery.dundee.ac.uk:studenttheses/39cd7ecc-d09b-4295-933e-725538437046","https://discovery.dundee.ac.uk/en/studentTheses/39cd7ecc-d09b-4295-933e-725538437046"],"dc:identifier.uri":["https://discovery.dundee.ac.uk/files/4439298/Pavic_phd_2013.pdf"],"dc:language":["eng"],"dc:publisher.institution":["University of Dundee","European Molecular Biology Laboratory"],"dc:relation.isreferencedby":["https://discovery.dundee.ac.uk/en/studentTheses/39cd7ecc-d09b-4295-933e-725538437046"],"dc:title":["The Development of Photo-crosslinkable Trapping Mutants as Tools to Investigate the Interactions of Protein Tyrosine Phosphatases"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["Doctoral Thesis"],"dc:type.qualificationname":["Doctor of Philosophy"]},"updated_at":"2026-07-24T02:07:52Z"}